ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Optimizing Kidney Transplant Immunosuppression Using a Phenotypic Personalized Dosing Model

J. F. Bruner1, N. Padmanabhan2, C. Ho2, A. Zarrinpar1

1Surgery, University of Florida, Gainesville, FL, 2Bioengineering, University of California, Los Angeles, Los Angeles, CA

Meeting: 2022 American Transplant Congress

Abstract number: 1704

Keywords: Immunosuppression, Infection, Kidney transplantation, Rejection

Topic: Clinical Science » Kidney » 38 - Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Information

Session Name: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Immunosuppression is essential for preventing rejection and promoting long-term graft survival following solid organ transplantation; it also places patients at risk for infection and toxicity. Immunosuppression management is further complicated by individual variability in drug dosing, metabolism, and immune response. Hence adjusting immunosuppression continues to be a clinical challenge. We aimed to systematize multi-drug immunosuppression management in kidney transplantation using an artificial intelligence-based complex systems approach called phenotypic personalized medicine (PPM).

*Methods: PPM applies nonlinear regression to a patient’s clinical data to generate a mathematical representation of their response to immunosuppressive agents. This allows the identification of a combination of doses likely to produce a desired clinical outcome. For this project, our outcome was allograft status, informed by the donor-derived cell-free DNA fraction (dd-cfDNA).

Using PPM, we performed retrospective analysis on clinical data from 8 kidney transplant (KT) recipients to generate 17 IS dosing recommendations. Each recommendation is specific to both the patient and time of recommendation and is hence represented by a different equation with unique coefficients. As a result, we were able to sort recommendations by patient status at the time of the recommendation into stable (n = 7), infection (n = 6), or rejection (n = 5) groups.

We calculated recommended change in IS based on the difference between doses dictated by PPM and doses prescribed to patients. The strength of recommendations was quantified relative to the maximum for each immunosuppressive agent to reduce error caused by differences in scaling.

*Results: In a retrospective analysis of 8 kidney transplant patients, PPM successfully recommended increasing immunosuppression before and during patient rejection events. PPM also identified the need for decreased immunosuppression in patients who later developed infections. In cases of stable allograft status,PPM recommended a modest increase in immunosuppression.

*Conclusions: In this retrospective study of systematic AI-based individualized dosing, we have demonstrated a potential actionable strategy for multi-drug immunosuppression management.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Bruner JF, Padmanabhan N, Ho C, Zarrinpar A. Optimizing Kidney Transplant Immunosuppression Using a Phenotypic Personalized Dosing Model [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/optimizing-kidney-transplant-immunosuppression-using-a-phenotypic-personalized-dosing-model/. Accessed June 6, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences